Physician profile
Kierney E Jackson
NPI 1003057621
$4,347.61
in general payments reported to CMS, 2019-2025
25 companies · $2,274 in 2025
The $2,274 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $487 · 2023: $682 · 2024: $582 · 2025: $2,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,164 · Travel and Lodging: $1,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,164.12 |
| Travel and Lodging | $1,373.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,380.13 | 2022-2025 | Indigo System, Penumbra System, Smart Coil |
| Organogenesis INC. | $645.51 | 2021-2025 | Puraply, Puraply Wound Matrix, Via Matrix |
| Janssen Pharmaceuticals, INC | $484.07 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $259.17 | 2021-2025 | Varithena Administration Pack, General - Therapies |
| Kerecis Limited | $101.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $72.40 | 2023 | |
| Lemaitre Vascular, INC. | $46.25 | 2024-2025 | Artegraft Vascular Graft |
| Solventum Corporation | $38.14 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Smith+Nephew, INC. | $35.82 | 2023-2024 | Stravix, Grafix, Grafix Pl |
| Silk Road Medical, INC. | $30.39 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $23.88 | 2022 | |
| Endologix LLC | $23.49 | 2023 | Alto Abdominal Stent Graft System |
| Atricure, INC. | $23.22 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Novo Nordisk INC | $19.27 | 2025 | Wegovy |
| Inspiremd Ltd | $18.52 | 2025 | Cguard Prime Carotid Stent System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mozarc Medical US LLC | $18.15 | 2023 | Palindrome |
| W. L. Gore & Associates, INC. | $17.09 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Shockwave Medical, INC | $16.63 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.63 | 2021 | |
| Baxter Healthcare | $14.71 | 2023 | Floseal |
| Veryan Medical Incorporated | $13.81 | 2022 | |
| Bard Peripheral Vascular, INC. | $13.50 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.10 | 2021 | |
| Abbott Laboratories | $11.80 | 2021 | |
| Medtronic, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kierney Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.